Search

Your search keyword '"PAGANI, OLIVIA"' showing total 281 results

Search Constraints

Start Over You searched for: Author "PAGANI, OLIVIA" Remove constraint Author: "PAGANI, OLIVIA" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
281 results on '"PAGANI, OLIVIA"'

Search Results

1. A Breast Cancer Smartphone App to Navigate the Breast Cancer Journey: Mixed Methods Study

2. Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland

3. Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

4. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

7. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

12. Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

13. Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice

15. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland : Findings from an International Workshop

17. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

24. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

25. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

28. Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

31. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

32. Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement

34. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

35. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.

37. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

38. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

40. Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer.

49. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Catalog

Books, media, physical & digital resources